
    
      Rapid MRI scans from Stage I-IV non-small-cell lung cancer (NSCLC) patients will be acquired.
      MR acquisition will be performed without extrinsically administered contrast, using a
      balanced turbo field echo (TFE) sequence and commercially available coils.
    
  